These ASX 200 Shares Could Rise 20% to 65%
Brokers Name 3 ASX Shares to Buy Today 17 January 2025
Citi Keeps Their Hold Rating on Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD)
ResMed Download Growth Hints at Possible Sales Beat -- Market Talk
Goldman Sachs Tips ResMed Shares to Rocket 30% to a Record High
ResMed Initiated at Buy by Goldman Sachs
ResMed Shares Are up 42% in a Year. This Shows Why They Could Still Be Great Value
ARAY Stock Gains as China Approves Latest Radiation Therapy Solutions
Scoop Up These 4 GARP Stocks to Receive Handsome Returns
Should You Consider Retaining ZBH Stock in Your Portfolio Now?
Is There An Opportunity With ResMed Inc.'s (NYSE:RMD) 31% Undervaluation?
Express News | Resmed Inc : Piper Sandler Initiates Coverage With Neutral Rating; Target Price $252
3 ASX 200 Healthcare Stocks With 'Strong Return Potential' in 2025
ResMed Inc: Notification of Results/Reporting Date
3 S&P 500 Earnings Growth Stocks to Buy in 2025: CMG, RMD, NOW
5 Australian Stocks to Hold for the Next Decade
HOLX Stock Gains Following the Acquisition of Gynesonics
ResMed Inc. Reports Change in Beneficial Ownership
Declining Stock and Solid Fundamentals: Is The Market Wrong About ResMed Inc. (NYSE:RMD)?
Resmed Chief Legal Officer Sells Shares